E
Ensysce Biosciences, Inc. (ENSC)
NCM – Real Time Price. Currency in USD
0.32
-0.07 (-17.15%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
0.32
-0.07 (-17.15%)
At close: May 12, 2026, 4:00 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 1.59 | 6.05 | 8.0 | |
| Quick ratio | 1.59 | 5.63 | 8.0 | |
| Debt to Equity | 0.09 | 0.30 | 9.0 | |
| Debt to Assets | 0.04 | 1.04 | 9.0 | |
| Interest coverage | -516.87 | -16.91 | 1.0 | |
| Weighted average score | 7.0 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 3M | 2M | 5M | 5M | 5M |
| Gross Profit | N/A | N/A | N/A | N/A | N/A |
| Operating Income | -24M | -11M | -7M | -10M | -10M |
| Net Income | -24M | -11M | -8M | -10M | -10M |
| EBITDA | -24M | -11M | -7M | -10M | -10M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 45.04 | 47.48 | 10 |
| Next quarter | N/A | 10.13 | 4.0 |
| Current year | 50.98 | 11.06 | 8.5 |
| Next year | -67.53 | N/A | 1.0 |
| Weighted average score | 5.9 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 281.73 | 25.78 | 41.86 | 23.32 | 10 |
| Y/Y | 44.39 | 22.35 | 74.14 | -99.68 | 7.8 |
| 3y average | 39.75 | 17.81 | 69.53 | 21.48 | 9.8 |
| 5y average | 16.11 | -10252.08 | 60.79 | -122.66 | 5.3 |
| Weighted average score | 8.2 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $4.3M significantly exceed its total debt $279.9K, ensuring strong financial flexibility
Total current assets $7.2M exceed Total current liabilities $4.6M, highlighting excellent liquidity
Debt-to-equity ratio (0.1) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-516.9x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$1.5M limits the company's ability to reinvest or pay down debt